Routine Chromosomal Microarray Analysis is Necessary in Korean Patients With Unexplained Developmental Delay/Mental Retardation/Autism Spectrum Disorder

BACKGROUND: All over the world, chromosomal microarray (CMA) is now the first tier diagnostic assay for genetic testing to evaluate developmental delay (DD), mental retardation (MR), and autism spectrum disorder (ASD) with unknown etiology. The average diagnostic yield of the CMA test is known to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Saeam, Yu, Nae, Choi, Jong Rak, Jeong, Seri, Lee, Kyung-A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510504/
https://www.ncbi.nlm.nih.gov/pubmed/26206688
http://dx.doi.org/10.3343/alm.2015.35.5.510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510504/
https://www.ncbi.nlm.nih.gov/pubmed/26206688
http://dx.doi.org/10.3343/alm.2015.35.5.510

Ejemplares similares